Oyster Point Pharma

Oyster Point Pharma is a commercial-stage biopharmaceutical company developing therapies for ophthalmic diseases.

Eye
Biotech

Oyster Point confirms around 50 layoffs in June

Oyster Point Pharma confirmed it laid off around 50 employees as part of cost-cutting measures to claw back over $50 million by the end of 2023.
James Waldron Aug 12, 2022 9:52am